19-40394272-TTCC-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_181882.3(PRX):βc.4077_4079delβ(p.Glu1361del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 1,368,446 control chromosomes in the GnomAD database, including 726 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.021 ( 139 hom., cov: 32)
Exomes π: 0.017 ( 587 hom. )
Consequence
PRX
NM_181882.3 inframe_deletion
NM_181882.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-40394272-TTCC-T is Benign according to our data. Variant chr19-40394272-TTCC-T is described in ClinVar as [Benign]. Clinvar id is 215547.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-40394272-TTCC-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.4077_4079del | p.Glu1361del | inframe_deletion | 7/7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.4362_4364del | p.Glu1456del | inframe_deletion | 7/7 | NP_001398056.1 | ||
PRX | XM_017027047.2 | c.3975_3977del | p.Glu1327del | inframe_deletion | 4/4 | XP_016882536.1 | ||
PRX | NM_020956.2 | c.*4282_*4284del | 3_prime_UTR_variant | 6/6 | NP_066007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRX | ENST00000324001.8 | c.4077_4079del | p.Glu1361del | inframe_deletion | 7/7 | 1 | NM_181882.3 | ENSP00000326018 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0214 AC: 3222AN: 150898Hom.: 137 Cov.: 32
GnomAD3 genomes
AF:
AC:
3222
AN:
150898
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0729 AC: 10638AN: 145830Hom.: 411 AF XY: 0.0651 AC XY: 5090AN XY: 78150
GnomAD3 exomes
AF:
AC:
10638
AN:
145830
Hom.:
AF XY:
AC XY:
5090
AN XY:
78150
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0173 AC: 21017AN: 1217436Hom.: 587 AF XY: 0.0175 AC XY: 10444AN XY: 596600
GnomAD4 exome
AF:
AC:
21017
AN:
1217436
Hom.:
AF XY:
AC XY:
10444
AN XY:
596600
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0214 AC: 3231AN: 151010Hom.: 139 Cov.: 32 AF XY: 0.0230 AC XY: 1698AN XY: 73744
GnomAD4 genome
AF:
AC:
3231
AN:
151010
Hom.:
Cov.:
32
AF XY:
AC XY:
1698
AN XY:
73744
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:4Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 13, 2015 | - - |
Charcot-Marie-Tooth disease Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | research | Genesis Genome Database | Aug 14, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Charcot-Marie-Tooth disease type 4 Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Uncertain significance, no assertion criteria provided | research | Genesis Genome Database | Aug 14, 2019 | - - |
Charcot-Marie-Tooth disease type 5 Uncertain:1
Uncertain significance, no assertion criteria provided | research | Genesis Genome Database | Aug 14, 2019 | - - |
Charcot-Marie-Tooth disease, type I Uncertain:1
Uncertain significance, no assertion criteria provided | research | Genesis Genome Database | Aug 14, 2019 | - - |
Spinocerebellar ataxia 46 Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Charcot-Marie-Tooth disease type 4F Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 24, 2017 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at